Lukas Englmaier
@lukasenglmaier
PhD student in molecular biology. @villunger Lab at @CeMM_News. Into RNA modifications, cell death and immunology et. al. Own (unpopular) opinions. 🇦🇹
ID: 809098232903200768
14-12-2016 18:10:25
41 Tweet
145 Followers
243 Following
Finally out – we have determined the first single particle cryo-EM structures of the fully assembled Elongator complexes from yeast and mouse. Thank you @NAR_Open for highlighting our work as a #BreakthroughArticle and Narodowe Centrum Nauki, FNP Foundation for Polish Science and European Research Council (ERC) for funding🧵
A new episode of „Death in the Alps“ is coming. All about cell death signalling in health and disease. Book 07-11th of January 2024 in your calendar and express your interest by emailing to [email protected] so we can keep you posted! Please RT
🔝Im neuen #podcast "Sustainability Café" von Victoria Englmaier (she/her) und @RomanMesicek dreht sich alles rund um das Thema #Nachhaltigkeit. Die 1. Folge ist online. 🙌👏👏👏➡️ fh-krems.ac.at/fachhochschule…
Today is Rare Disease Day! We and our partner institutes St. Anna Children's Cancer Research Institute CCRI, CeMM and MedUni Wien want to raise awareness and show our commitment to the global effort to fight rare diseases. We care about rare - do you? Rare Disease Day
A novel Factor Associated with Metabolism and Energy (FAME) is a membrane-associated protein enriched in the kidney, pancreas, liver, and fallopian tube with #genetic variation in FAME linked to higher body mass index in humans Nature Communications nature.com/articles/s4146…
Happy to share the news that the PIDDosome can control sterile inflammation in cells with extra centrosomes. @imed_tweets , CeMM Papers, ECDO Thanks to Irmina and team for all the hard work European Research Council (ERC) embopress.org/doi/full/10.15…
We are excited to share our new versatile technique "BEE-ST" that allows precise quantification of hard tissue (🦴and🦷) development and healing across species! 🐭🦎🐟🐸🐔 New in Science Magazine #ScienceAdvancesResearch science.org/doi/10.1126/sc…
Out today Nature Methods! Excited to share our work on a new method (RUBICON) based on a chemical probe to target in situ, enrich and profile endogenous disordered proteins in cells, including #IDPs and those that acquire disorder. #ozchem #proteostasis rdcu.be/d1ru3